EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Advances in the Study of KRAS in Brain Arteriovenous Malformation

Miao Pang, Guanghao Zhang, Chenghao Shang, Yuhang Zhang, Rundong Chen, Zhe Li, Xin Ding, Guoli Duan, Qiang Li

Cerebrovascular Diseases · 2023

DOI: 10.1159/000535139 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cerebrovascular Diseases, 2023. Verfasst von Miao Pang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Intracranial Arteriovenous Malformations, Proto-Oncogene Proteins p21(ras), Mutation, Signal Transduction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Brain arteriovenous malformation (bAVM) is an abnormal vascular mass with disordered arteriovenous connection. Endothelial KRAS mutation is common in bAVM. In vivo studies have demonstrated that mutations of KRAS in somatic cells can induce bAVM-like angiogenesis, suggesting that KRAS gene may play a key role in the development and progression of bAVM. Summary: In this article, we will provide a comprehensive review of action mechanisms of KRAS mutations in the development of bAVM and summarize potential targeting drugs for KRAS mutations in bAVM somatic cells. Key Message: KRAS mutation in human brain endothelial cells is a key driver in the pathogenesis of sporadic cerebral arteriovenous malformations. It is of great clinical importance to explore and summarize the changes in the signaling pathway induced by KRAS mutation, which may provide additional targets for the treatment of sporadic bAVM development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intracranial Arteriovenous MalformationsProto-Oncogene Proteins p21(ras)MutationSignal TransductionHumansAnimalsEndothelial CellsGenetic Predisposition to DiseaseNeovascularization, PathologicPhenotypeAngiogenesis Inhibitors

Stichwörter der Autor:innen

AngiogenesisBrain arteriovenous malformationEndothelial cellKRASSomatic mutationsTherapeutic targets

Substanzen

Proto-Oncogene Proteins p21(ras)KRAS protein, humanAngiogenesis Inhibitors

Autor:innen und Institutionen

  • Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
  • School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.

Zitieren

APA

Pang, M., Zhang, G., Shang, C., Zhang, Y., Chen, R., Li, Z., Ding, X., Duan, G., & Li, Q. (2023). Advances in the Study of KRAS in Brain Arteriovenous Malformation. Cerebrovascular Diseases. https://doi.org/10.1159/000535139

Vancouver

Pang M, Zhang G, Shang C, Zhang Y, Chen R, Li Z, et al. Advances in the Study of KRAS in Brain Arteriovenous Malformation. Cerebrovascular Diseases. 2023. doi:10.1159/000535139

BibTeX
@article{Pang2023,
  author = {Pang, Miao and Zhang, Guanghao and Shang, Chenghao and Zhang, Yuhang and Chen, Rundong and Li, Zhe and Ding, Xin and Duan, Guoli and Li, Qiang},
  title = {Advances in the Study of KRAS in Brain Arteriovenous Malformation},
  journal = {Cerebrovascular Diseases},
  year = {2023},
  doi = {10.1159/000535139}
}
Kostenlos starten →